Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid Tumors
Liquid biopsies show promise for pediatric cancer prognosis and treatment guidance, though standardization work remains essential before routine clinical use.
This ASCO Education Book review comprehensively covers the biomarker landscape for pediatric solid tumors, with particular focus on liquid biopsy's emerging role in prognosis and immunotherapy guidance across neuroblastoma, rhabdomyosarcoma, Ewing sarcoma, and others. The review highlights that while liquid biopsy holds promise, standardization and clinical validation remain significant challenges in the pediatric oncology setting.
What the study was
- Study design
- Review article (ASCO Education Book)
- Population
- Pediatric patients with extracranial solid tumors
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Am Soc Clin Oncol Educ Book
Why it surfaced
ASCO Education Book authoritative review covering liquid biopsy + immunotherapy biomarkers in pediatric solid tumors. High clinical utility as reference; review format limits evidence score.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.